| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Immunology and Rheumatology, Department of Medicine, and
Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305; and
La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
We have used multicolor FACS analysis, immunohistology, and functional assays to study the expression of CD1 on B cell subsets from normal and ß2m-/- mice. Two B cell subpopulations were identified that express high levels of CD1 in normal mice: splenic marginal zone B cells (IgMhigh IgDlow CD21high CD24intermediate CD23- CD43-) and a newly identified subpopulation of follicular B cells. The latter cells are unusual, because they are IgDhigh CD23+, like follicular B cells, but express high levels of CD21 and IgM, an expression pattern that is associated with marginal zone B cells. Therefore, the high-level expression of CD1 and CD21 was found to be closely associated on splenic B cells. Immunohistology confirmed the expression of CD1 on marginal zone B cells and on clusters of B cells in splenic follicles. Both the high-level CD1 expression by these cells and the low-level CD1 expression by subpopulations of B cells in the spleen, lymph node, peritoneal cavity, and bone marrow were markedly reduced in ß2m-/- mice. Despite this, a CD1-restricted T cell clone proliferated vigorously in response to LPS-activated spleen cells that had been obtained from both ß2m-/- and wild-type mice. This response was inhibited by the 3C11 anti-CD1 mAb. These results show the heterogeneity of B cell subsets in their expression of the ß2m-dependent form of CD1. They further suggest that a ß2m-independent form of CD1 is expressed on B cells that can stimulate T cells; however, this form is not easily visualized with the anti-CD1 mAb used here.
This article has been cited by other articles:
|
|
 |
|
  Y. You, H. Zhao, Y. Wang, and R. H. Carter Cutting Edge: Primary and Secondary Effects of CD19 Deficiency on Cells of the Marginal Zone J. Immunol., June 15, 2009; 182(12): 7343 - 7347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Kim, M. Pichavant, P. Matangkasombut, Y. I. Koh, P. B. Savage, R. H. DeKruyff, and D. T. Umetsu The Development of Airway Hyperreactivity in T-bet-Deficient Mice Requires CD1d-Restricted NKT Cells J. Immunol., March 1, 2009; 182(5): 3252 - 3261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tsunoda, T. Tanaka, and R. S. Fujinami Regulatory Role of CD1d in Neurotropic Virus Infection J. Virol., October 15, 2008; 82(20): 10279 - 10289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. I. Koh, H. Y. Kim, E. H. Meyer, M. Pichavant, O. Akbari, T. Yasumi, P. B. Savage, R. H. DeKruyff, and D. T. Umetsu Activation of Nonclassical CD1d-Restricted NK T Cells Induces Airway Hyperreactivity in {beta}2-Microglobulin-Deficient Mice J. Immunol., October 1, 2008; 181(7): 4560 - 4569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Benatuil, J. Kaye, N. Cretin, J. G. Godwin, A. Cariappa, S. Pillai, and J. Iacomini Ig Knock-In Mice Producing Anti-Carbohydrate Antibodies: Breakthrough of B Cells Producing Low Affinity Anti-Self Antibodies J. Immunol., March 15, 2008; 180(6): 3839 - 3848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Marino, M. Batten, J. Groom, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey Marginal-Zone B-Cells of Nonobese Diabetic Mice Expand With Diabetes Onset, Invade the Pancreatic Lymph Nodes, and Present Autoantigen to Diabetogenic T-Cells Diabetes, February 1, 2008; 57(2): 395 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cariappa, C. Boboila, S. T. Moran, H. Liu, H. N. Shi, and S. Pillai The Recirculating B Cell Pool Contains Two Functionally Distinct, Long-Lived, Posttransitional, Follicular B Cell Populations J. Immunol., August 15, 2007; 179(4): 2270 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Belperron, C. M. Dailey, C. J. Booth, and L. K. Bockenstedt Marginal Zone B-Cell Depletion Impairs Murine Host Defense against Borrelia burgdorferi Infection Infect. Immun., July 1, 2007; 75(7): 3354 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kumazaki, B. Tirosh, R. Maehr, M. Boes, T. Honjo, and H. L. Ploegh AID-/-{micro}s-/- Mice Are Agammaglobulinemic and Fail to Maintain B220-CD138+ Plasma Cells J. Immunol., February 15, 2007; 178(4): 2192 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Srivastava, W. J. Quinn III, K. Hazard, J. Erikson, and D. Allman Characterization of marginal zone B cell precursors J. Exp. Med., November 7, 2005; 202(9): 1225 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Geng, P. Laslo, K. Barton, and C.-R. Wang Transcriptional Regulation of CD1D1 by Ets Family Transcription Factors J. Immunol., July 15, 2005; 175(2): 1022 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Bezbradica, A. K. Stanic, N. Matsuki, H. Bour-Jordan, J. A. Bluestone, J. W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce Distinct Roles of Dendritic Cells and B Cells in Va14Ja18 Natural T Cell Activation In Vivo J. Immunol., April 15, 2005; 174(8): 4696 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rolf, V. Motta, N. Duarte, M. Lundholm, E. Berntman, M.-L. Bergman, L. Sorokin, S. L. Cardell, and D. Holmberg The Enlarged Population of Marginal Zone/CD1dhigh B Lymphocytes in Nonobese Diabetic Mice Maps to Diabetes Susceptibility Region Idd11 J. Immunol., April 15, 2005; 174(8): 4821 - 4827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Kobrynski, A. O. Sousa, A. J. Nahmias, and F. K. Lee Cutting Edge: Antibody Production to Pneumococcal Polysaccharides Requires CD1 Molecules and CD8+ T Cells J. Immunol., February 15, 2005; 174(4): 1787 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lin, T. J. Roberts, P. M. Spence, and R. R. Brutkiewicz Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection J. Leukoc. Biol., February 1, 2005; 77(2): 151 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kanayama, M. Cascalho, and H. Ohmori Analysis of Marginal Zone B Cell Development in the Mouse with Limited B Cell Diversity: Role of the Antigen Receptor Signals in the Recruitment of B Cells to the Marginal Zone J. Immunol., February 1, 2005; 174(3): 1438 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Girkontaite, V. Sakk, M. Wagner, T. Borggrefe, K. Tedford, J. Chun, and K.-D. Fischer The Sphingosine-1-Phosphate (S1P) Lysophospholipid Receptor S1P3 Regulates MAdCAM-1+ Endothelial Cells in Splenic Marginal Sinus Organization J. Exp. Med., December 6, 2004; 200(11): 1491 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Ferguson, M. E. Youd, and R. B. Corley Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells Int. Immunol., October 1, 2004; 16(10): 1411 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Whipple, R. S. Shanahan, A. H. Ditto, R. P. Taylor, and M. A. Lindorfer Analyses of the In Vivo Trafficking of Stoichiometric Doses of an Anti-Complement Receptor 1/2 Monoclonal Antibody Infused Intravenously in Mice J. Immunol., August 15, 2004; 173(4): 2297 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Atencio, H. Amano, S. Izui, and B. L. Kotzin Separation of the New Zealand Black Genetic Contribution to Lupus from New Zealand Black Determined Expansions of Marginal Zone B and B1a Cells J. Immunol., April 1, 2004; 172(7): 4159 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Goodyear, M. Narita, and G. J. Silverman In Vivo VL-Targeted Activation-Induced Apoptotic Supraclonal Deletion by a Microbial B Cell Toxin J. Immunol., March 1, 2004; 172(5): 2870 - 2877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Heltemes-Harris, X. Liu, and T. Manser Progressive Surface B Cell Antigen Receptor Down-Regulation Accompanies Efficient Development of Antinuclear Antigen B Cells to Mature, Follicular Phenotype J. Immunol., January 15, 2004; 172(2): 823 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lee and D. E. Geraghty HLA-F Surface Expression on B Cell and Monocyte Cell Lines Is Partially Independent from Tapasin and Completely Independent from TAP J. Immunol., November 15, 2003; 171(10): 5264 - 5271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Witt, W.-J. Won, V. Hurez, and C. A. Klug Notch2 Haploinsufficiency Results in Diminished B1 B Cells and a Severe Reduction in Marginal Zone B Cells J. Immunol., September 15, 2003; 171(6): 2783 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Amano, E. Amano, T. Moll, D. Marinkovic, N. Ibnou-Zekri, E. Martinez-Soria, I. Semac, T. Wirth, L. Nitschke, and S. Izui The Yaa Mutation Promoting Murine Lupus Causes Defective Development of Marginal Zone B Cells J. Immunol., March 1, 2003; 170(5): 2293 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Samardzic, D. Marinkovic, P. J. Nielsen, L. Nitschke, and T. Wirth BOB.1/OBF.1 Deficiency Affects Marginal-Zone B-Cell Compartment Mol. Cell. Biol., December 1, 2002; 22(23): 8320 - 8331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Kang and P. Cresswell Calnexin, Calreticulin, and ERp57 Cooperate in Disulfide Bond Formation in Human CD1d Heavy Chain J. Biol. Chem., November 15, 2002; 277(47): 44838 - 44844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Won and J. F. Kearney CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice J. Immunol., June 1, 2002; 168(11): 5605 - 5611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Tumas-Brundage, E. Notidis, L. Heltemes, X. Zhang, L. J. Wysocki, and T. Manser Predominance of a novel splenic B cell population in mice expressing a transgene that encodes multireactive antibodies: support for additional heterogeneity of the B cell compartment Int. Immunol., April 1, 2001; 13(4): 475 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dao, M. Exley, W. Z. Mehal, S. M. A. Tahir, S. Snapper, M. Taniguchi, S. P. Balk, and I. N. Crispe Involvement of CD1 in Peripheral Deletion of T Lymphocytes Is Independent of NK T Cells J. Immunol., March 1, 2001; 166(5): 3090 - 3097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Batten, J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay Baff Mediates Survival of Peripheral Immature B Lymphocytes J. Exp. Med., November 20, 2000; 192(10): 1453 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kumar, A. Belperron, S. W. Barthold, and L. K. Bockenstedt Cutting Edge: CD1d Deficiency Impairs Murine Host Defense Against the Spirochete, Borrelia burgdorferi J. Immunol., November 1, 2000; 165(9): 4797 - 4801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zeng, M.-K. Lee, J. Tung, A. Brendolan, and S. Strober Cutting Edge: A Role for CD1 in the Pathogenesis of Lupus in NZB/NZW Mice J. Immunol., May 15, 2000; 164(10): 5000 - 5004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zeng, G. Gazit, S. Dejbakhsh-Jones, S. P. Balk, S. Snapper, M. Taniguchi, and S. Strober Heterogeneity of NK1.1+ T Cells in the Bone Marrow: Divergence from the Thymus J. Immunol., November 15, 1999; 163(10): 5338 - 5345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Kim, J. Garcia, M. Exley, K. W. Johnson, S. P. Balk, and R. S. Blumberg Biochemical Characterization of CD1d Expression in the Absence of beta 2-Microglobulin J. Biol. Chem., April 2, 1999; 274(14): 9289 - 9295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Somnay-Wadgaonkar, A. Nusrat, H. S. Kim, W. P. Canchis, S. P. Balk, S. P. Colgan, and R. S. Blumberg Immunolocalization of CD1d in human intestinal epithelial cells and identification of a ß2-microglobulin-associated form Int. Immunol., March 1, 1999; 11(3): 383 - 392. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
